Health Bulletin 29/October/2021

Published On 2021-10-30 05:39 GMT   |   Update On 2021-10-30 05:39 GMT
Advertisement

Here are Top Health Stories of the day

Madras HC slams Medical Council for removing gastroenterologist's name, gives 14 pointer guidelines

Slamming the Tamil Nadu Medical Council's decision of removing a gastroenterologist's name from the medical register without providing any opportunity of defence to him, the Madras High Court has set aside the punishment of suspension imposed by the council.

Noting that the petitioner gastroenterologist was only a witness in disciplinary proceedings initiated against another doctor, the HC bench comprising of Justice R. Mahadevan observed that the doctor was in no way connected to the false medical certificate issued by the main accused doctor and therefore, there is absolutely no ground for taking disciplinary action against the petitioner doctor.

Advertisement

For more details, check out the full story on the link below:

Madras HC Slams Medical Council For Removing Gastroenterologist's Name, Gives 14 Pointer Guidelines

NEET candidate alleges manipulation in OMR sheet: HC orders NTA to conduct enquiry

While considering the allegations of a National Eligibility-cum-Entrance Test (NEET) candidate regarding the manipulation of the OMR sheet, the Kerala High Court has recently directed the National Testing Agency (NTA) to conduct an inquiry regarding the matter.

Further, the bench comprising of Justice N. Nagaresh has directed the NTA, the body responsible for conducting the centralized medical entrance test across India, to submit the report of the investigation before the High Court on or before November 8.

For more details, check out the full story on the link below:

NEET Candidate Alleges Manipulation In OMR Sheet: HC Orders NTA To Conduct Enquiry


Are Doctor Consultants different from Employees? SC questions during insolvency of hospital

The matter of whether there can be any discrimination between the consultant doctors and the employee doctors during the Corporate Insolvency Resolution Process of a hospital, is now being considered by the Apex Court.

This comes after a doctor approached the top court contending that such discrimination would violate Section 30(2) Explanation 1 of the Insolvency and Bankruptcy Code, Article 14 of the Constitution of India, and the top court judgment in the Committee of Creditors of Essar Steel India Limited v. Satish Kumar Gupta and Ors., adds Live Law.

For more details, check out the full story on the link below:

Are Doctor Consultants Different From Employees? SC Questions During Insolvency Of Hospital

Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication
In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to market its popular diabetes drug empagliflozin for an additional indication to reduce the risk of cardiovascular death plus hospitalisation for heart failure in adults with heart failure and reduced ejection fraction in adults.
This nod came after the firm presented the USFDA approval details for Empagliflozin Tablets 10/25mg as a new indication to reduce the risk of cardiovascular death plus hospitalisation for heart failure in adults with heart failure and reduced ejection fraction, in light of the SEC recommendation dated 09.03.2021 and 10.03.2021.

For more details, check out the full story on the link below:


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News